Peripheral IL-6/IL-17/NF-κB1 and IL-10 Signaling in Children with Autism Spectrum Disorder: Integrative
Yoosra Najim Abed Al-Saadi1, Zainab Basim Mohammed1, Mithal Abdulkareem Abdoun1
1Ibn Sina University of Medical and Pharmaceutical Sciences, Baghdad, Iraq.
This study reveals a pro-inflammatory pathway involving IL-6, IL-17, and NF-κB1 in autism spectrum disorder (ASD), with reduced IL-10 regulation. These findings suggest potential biomarkers and therapeutic targets for inflammation-associated ASD.
Area of Science:
- Neuroscience
- Immunology
- Genetics
Background:
- Autism spectrum disorder (ASD) is linked to immune and inflammatory dysregulation.
- The molecular links between peripheral immune signals and neuroinflammation in ASD are not well understood.
Purpose of the Study:
- To investigate inflammation-related molecular pathways in ASD using integrated transcriptomic network analysis.
- To validate key cytokine genes (IL6, IL10, IL17, NF-κB1) using quantitative real-time polymerase chain reaction (qRT-PCR).
Main Methods:
- Integrative computational-experimental approach using four gene expression omnibus (GEO) transcriptomic datasets.
- Construction of protein-protein interaction (PPI) networks to identify inflammation-related modules.
- Validation of selected inflammatory genes (IL6, IL10, IL17, NF-κB1) via qRT-PCR in peripheral blood samples from ASD patients and healthy controls.
Main Results:
- Identification of core differentially expressed genes (DEGs) and a connected PPI network with hub genes (PUM1, TRRAP, ILF3, INO80, PTBP1).
- Functional enrichment analysis indicated cytokine-mediated signaling, leukocyte activation, and neuroinflammation.
- qRT-PCR confirmed significant dysregulation of IL6, IL17, NF-κB1, and IL10 in ASD peripheral blood samples.
Conclusions:
- A central pro-inflammatory axis (IL-6/IL-17/NF-κB1) and reduced IL-10 regulation were identified in ASD.
- Peripheral immune activation and transcriptional regulators are implicated in ASD neuroinflammation.
- Identified hub genes and pathways may serve as biomarkers and therapeutic targets for an inflammation-associated ASD subtype.
More Related Videos
09:33Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
Published on: August 25, 2023
05:51A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
Published on: June 15, 2011
